Skip to main content

Drug Interactions between Ga 68 PSMA-11 and nilutamide

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

nilutamide gallium Ga-68 PSMA-11

Applies to: nilutamide and Ga 68 PSMA-11 (gallium ga 68 psma-11)

MONITOR: The concomitant use of antiandrogens or androgen deprivation therapy may affect the uptake of gallium Ga-68 PSMA-11, also known as gallium Ga-68 gozetotide, and diminish its diagnostic effects in patients with prostate cancer. However, the clinical impact of these drugs on the performance of gallium Ga-68 PSMA-11 has not been established.

MANAGEMENT: Clinicians should be aware of possible interference with diagnostic tests in patients who are taking these medications.

References

  1. (2022) "Product Information. Ga 68 PSMA-11 (gallium Ga-68 PSMA-11)." UCLA Biomedical Cyclotron Facility
  2. (2022) "Product Information. Locametz (gozetotide)." Advanced Accelerator Applications

Switch to consumer interaction data

Drug and food interactions

Moderate

nilutamide food

Applies to: nilutamide

GENERALLY AVOID: Alcohol intolerance has been reported in 5% to 20% of patients following administration of nilutamide in clinical studies. Symptoms include facial flushes, malaise, and hypotension.

MANAGEMENT: Consumption of alcoholic beverages should be avoided in patients who experience alcohol intolerance with nilutamide.

References

  1. (2001) "Product Information. Nilandron (nilutamide)." Hoechst Marion Roussel
  2. Decensi A, Guarneri D, Paoletti MC, Lalanne JM, Merlo F, Boccardo F (1991) "Phase II study of the pure non-steroidal antiandrogen nilutamide in prostatic cancer. Italian Prostatic Cancer Project (PONCAP)." Eur J Cancer, 27, p. 1100-4

Switch to consumer interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

See also

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer